Status:
COMPLETED
The Feasibility of Engage Therapy With Video Support for Homebound Older Adults
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Depression
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The primary aim in this pilot project is to test the feasibility, acceptability and impact (decreased depressive symptoms) of a brief behavioral treatment for depression (Engage) combined with video s...
Detailed Description
Engage is a brief therapy designed to offer a structured, stepped approach and interventions to reduce barriers to increased engagement with rewarding activities to improve depression (Alexopoulos et ...
Eligibility Criteria
Inclusion
- Age at least 60 years
- English speaking
- Currently enrolled in case management at in 2 included agencies
- Major depression on the SCID
- 24-item Hamilton Depression Rating Scale (HAM-D) ≥ 19
Exclusion
- Psychotic depression by SCID-V, i.e. presence of delusions
- High suicide risk, i.e. intent or plan to attempt suicide in the near future
- Presence of any Axis I psychiatric disorder
- Presence of substance abuse other than unipolar major depression
- History of psychiatric disorders, hypomania, are excluded
- Acute or severe medical illness, i.e. delirium, metastatic cancer, decompensated cardiac, liver, or kidney failure, major surgery, stroke, or myocardial infarction during the three months prior to entry; or drugs often causing depression, e.g. steroids, reserpine, alpha- methyl-dopa, tamoxiphen, vincristine
- Current involvement in psychotherapy
- Cognitive impairment (i.e. telephone administered MoCA \< 11)
- Currently dwelling in non-community dwelling (e.g. prison, nursing home)
- Hearing that would not allow participants to complete sessions with the RA/therapist
- Vision impairment that would not allow the participant to use the study provided tablet
- Inability to speak English
- Aphasia interfering with communication
- Literacy -assessed by reading a paragraph designed for those at 6th grade reading level
Key Trial Info
Start Date :
May 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT05346055
Start Date
May 12 2022
End Date
September 30 2022
Last Update
June 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine
New York, New York, United States, 10065